Key facts
- Synthpop’s last known valuation is $60.0M (Aug 2025).
- It has raised $23.2M across 2 recorded rounds; the latest was Early Stage VC ($15.0M) in Aug 2025.
- Notable investors include General Catalyst, Peterson Partners, Newfund Management, Page One Ventures, Defy Partners Management — 14 tracked in total.
- Synthpop has filed 2 Form Ds with the SEC since 2024, most recently Aug 2025 ($15.0M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Synthpop
Funding rounds
2 roundsAbout Synthpop
Operator of an artificial intelligence-based healthcare workflow platform designed to provide real-time feedback and summarization. The company's platform leverages multimodal large language models and simplifies the handling of incoming, multi-page orders by sorting faxes, then examining and validating new orders against clinical and payor guidelines, enabling doctors to improve their clinical workflows and perform complex healthcare administrative tasks.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2023
- Employees
- 23
- Website
- synthpop.ai/
- Ownership
- Privately Held (backing)
Synthpop doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synthpop shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synthpop in its N-PORT filings yet. We sweep new filings monthly.